🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Payel Roy

ORCID: 0000-0002-8177-2058
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.818Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135
Top 25%
0.818DataRank
Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Papers

Driven by 7 papers — median percentile 75. Top paper: “Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design”.

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100135
Top 25%
0.818DataRank
Top 25%12 citations

Katherine Callaway Kim, Katie J. Suda, Jing Luo, Xiaoming Wang, Donna Olejniczak +2 more

Confronting Covid, Racism, and Addiction: The Association of Multidisciplinary Education and Research in Substance use and Addiction (Amersa)

Substance Abuse(2021)10.1080/08897077.2020.1866144
N/A
0DataRank · unranked
8 citations

Deborah S. Finnell, Payel Roy, Rebecca Northup, Doreen MacLane-Baeder, Shannon Mountain-Ray

Appointment wait-times and arrival for patients at a low-barrier access addiction clinic

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.108011
N/A
0DataRank · unranked
60 citations

Sugy Choi, Edward Bernstein, Alexander Y. Walley, Payel Roy

Changes in Buprenorphine Prescribing After X-Waiver Exemptions: An Interrupted Time Series Analysis

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110167
N/A
0DataRank · unranked
0 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more

Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder

Addiction(2025)10.1111/add.70288
N/A
0DataRank · unranked
1 citations

Ryan Colvin, Katelin B. Nickel, Rachael K. Ross, Michael J. Durkin, Katie J. Suda +3 more

Trends in Initiation of Buprenorphine for Opioid Use Disorder Among Older Adults

Journal of the American Geriatrics Society(2025)10.1111/jgs.70182
N/A
0DataRank · unranked
0 citations

Roisin Sabol, Bryant Shuey, Payel Roy, Katie J. Suda, Tae Woo Park +2 more

Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104381
N/A
0DataRank · unranked
36 citations

Katie J. Suda, Jing Luo, MyoungKeun Lee, Joel Anderton, Donna Olejniczak +2 more